Summary by Futu AI
On June 14, 2024, Baker Bros. Advisors LP, along with related entities and individuals, filed a Schedule 13D with the United States Securities and Exchange Commission (SEC), indicating a significant ownership stake in HOOKIPA Pharma Inc. The filing revealed that Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, and managing members Julian C. Baker and Felix J. Baker collectively hold 9,813,151 shares of HOOKIPA Pharma, representing 9.99% of the company's class of common stock. This stake includes 1,685,000 shares issuable upon the conversion of Series A-2 Preferred Stock, subject to certain limitations. The shares were acquired through a combination of open market purchases, transactions with underwriters, and conversions of securities previously obtained in private transactions with the issuer. The total investment reported by the...Show More